📣 VC round data is live. Check it out!

M1 Kliniken Valuation Multiples

Discover revenue and EBITDA valuation multiples for M1 Kliniken and similar public comparables like Community Health Systems, AirSculpt, Chularat Hospital, Sikarin and more.

M1 Kliniken Overview

About M1 Kliniken

M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.


Founded

2007

HQ

Germany

Employees

199

Financials (LTM)

Revenue: $320M
EBITDA: $44M

EV

$366M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

M1 Kliniken Financials

M1 Kliniken reported last 12-month revenue of $320M and EBITDA of $44M.

In the same LTM period, M1 Kliniken generated $44M in EBITDA and $25M in net income.

Revenue (LTM)


M1 Kliniken P&L

In the most recent fiscal year, M1 Kliniken reported revenue of $427M and EBITDA of $47M.

M1 Kliniken is profitable as of last fiscal year, with gross margin of 22%, EBITDA margin of 11%, and net margin of 6%.

See analyst estimates for M1 Kliniken
LTMLast FY202320242025202620272028
Revenue$320M$427M$367M$394M$423M
Gross Profit—$96M$58M$74M$96M
Gross Margin—22%16%19%23%
EBITDA$44M$47M$27M$39M$47M
EBITDA Margin14%11%7%10%11%
EBIT Margin12%10%5%8%10%
Net Profit$25M$27M$12M$19M$26M
Net Margin8%6%3%5%6%

Financial data powered by Morningstar, Inc.

M1 Kliniken Stock Performance

M1 Kliniken has current market cap of $412M, and enterprise value of $366M.

Market Cap Evolution


M1 Kliniken's stock price is $21.96.

M1 Kliniken share price increased by 8.0% in the last 30 days, and by 41.0% in the last year.

M1 Kliniken has an EPS (earnings per share) of $1.44.

See more trading valuation data for M1 Kliniken
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$366M$412M-0.7%8.0%7.9%41.0%$1.44

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

M1 Kliniken Valuation Multiples

M1 Kliniken trades at 1.1x EV/Revenue multiple, and 8.3x EV/EBITDA.

See NTM and 2027E valuation multiples for M1 Kliniken

EV / Revenue (LTM)


M1 Kliniken Financial Valuation Multiples

As of May 24, 2026, M1 Kliniken has market cap of $412M and EV of $366M.

M1 Kliniken has a P/E ratio of 16.2x.

LTMLast FY202320242025202620272028
EV/Revenue1.1x0.9x1.0x0.9x0.9x
EV/EBITDA8.3x7.8x13.7x9.4x7.8x
EV/EBIT9.2x8.6x21.5x12.1x8.6x
EV/Gross Profit—3.8x6.3x5.0x3.8x
P/E16.2x15.3x34.6x22.2x16.1x
EV/FCF7.5x8.3x46.4x10.7x8.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified M1 Kliniken Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

M1 Kliniken Margins & Growth Rates

M1 Kliniken decreased revenue by 63% and EBITDA by 14% in the last fiscal year.

In the most recent fiscal year, M1 Kliniken reported gross margin of 22%, EBITDA margin of 11%, and net margin of 6%.

See estimated margins and future growth rates for M1 Kliniken

M1 Kliniken Margins

Last FY202420252026202720282029
Gross Margin22%19%23%—
EBITDA Margin11%10%11%26%
EBIT Margin10%8%10%25%
Net Margin6%5%6%15%
FCF Margin10%9%10%43%

M1 Kliniken Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(63%)7%7%(63%)
Gross Profit Growth—27%30%—
EBITDA Growth(14%)45%21%(14%)
EBIT Growth(10%)78%41%(10%)
Net Profit Growth(14%)56%38%(10%)
FCF Growth53%335%28%53%

Data powered by FactSet, Inc. and Morningstar, Inc.

M1 Kliniken Operational KPIs

M1 Kliniken's revenue per employee in the last FY averaged $2.1M, while opex per employee averaged $0.3M for the same period.

M1 Kliniken's Rule of 40 is (37%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

M1 Kliniken's Rule of X is (132%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for M1 Kliniken
LTMLast FY202320242025202620272028
Rule of 40(41%)(37%)———
Bessemer Rule of X(123%)(132%)———
Revenue per Employee—$2.1M———
Opex per Employee—$0.3M———
S&M Expenses to Revenue—1%1%1%1%
G&A Expenses to Revenue—1%1%1%1%
Opex to Revenue—12%11%11%13%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

M1 Kliniken Competitors

M1 Kliniken competitors include Community Health Systems, AirSculpt, Chularat Hospital, Sikarin, Mater Dei, OncoclĂ­nicas, Auna, Medica Sur, Al-Maidan Dental Clinic and Pihlajalinna.

Most M1 Kliniken public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Community Health Systems0.8x0.9x5.2x7.2x
AirSculpt2.8x2.8x28.4x28.0x
Chularat Hospital1.5x1.6x7.5x7.5x
Sikarin2.3x—8.8x—
Mater Dei1.5x1.5x5.9x6.7x
OncoclĂ­nicas0.9x0.9x(3.2x)(7.8x)
Auna1.0x1.0x4.9x4.8x
Medica Sur1.0x1.0x4.5x5.0x

This data is available for Pro users. Sign up to see all M1 Kliniken competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About M1 Kliniken

When was M1 Kliniken founded?M1 Kliniken was founded in 2007.
Where is M1 Kliniken headquartered?M1 Kliniken is headquartered in Germany.
How many employees does M1 Kliniken have?As of today, M1 Kliniken has over 199 employees.
Is M1 Kliniken publicly listed?Yes, M1 Kliniken is a public company listed on Frankfurt Stock Exchange.
What is the stock symbol of M1 Kliniken?M1 Kliniken trades under M12 ticker.
When did M1 Kliniken go public?M1 Kliniken went public in 2015.
Who are competitors of M1 Kliniken?M1 Kliniken main competitors include Community Health Systems, AirSculpt, Chularat Hospital, Sikarin, Mater Dei, OncoclĂ­nicas, Auna, Medica Sur, Al-Maidan Dental Clinic, Pihlajalinna.
What is the current market cap of M1 Kliniken?M1 Kliniken's current market cap is $412M.
What is the current revenue of M1 Kliniken?M1 Kliniken's last 12 months revenue is $320M.
What is the current revenue growth of M1 Kliniken?M1 Kliniken revenue growth (NTM/LTM) is (55%).
What is the current EV/Revenue multiple of M1 Kliniken?Current revenue multiple of M1 Kliniken is 1.1x.
Is M1 Kliniken profitable?Yes, M1 Kliniken is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of M1 Kliniken?M1 Kliniken's last 12 months EBITDA is $44M.
What is M1 Kliniken's EBITDA margin?M1 Kliniken's last 12 months EBITDA margin is 14%.
What is the current EV/EBITDA multiple of M1 Kliniken?Current EBITDA multiple of M1 Kliniken is 8.3x.
What is the current FCF of M1 Kliniken?M1 Kliniken's last 12 months FCF is $49M.
What is M1 Kliniken's FCF margin?M1 Kliniken's last 12 months FCF margin is 15%.
What is the current EV/FCF multiple of M1 Kliniken?Current FCF multiple of M1 Kliniken is 7.5x.
How many companies M1 Kliniken has acquired to date?M1 Kliniken hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies M1 Kliniken has invested to date?M1 Kliniken hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to M1 Kliniken

Lists including M1 Kliniken

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial